Intravenous Access Devices Market is estimated to be US$ 96.6 Billion by 2034 with a CAGR of 6.20% during the forecast period

 

Intravenous access devices are medical devices used to gain access to a patient's bloodstream for the delivery of fluids, medications, or blood products. They are commonly employed in hospitals, clinics, and other healthcare settings where intravenous (IV) therapy is administered.

Healthcare professionals are becoming more aware of the importance of proper intravenous access and the selection of appropriate devices. Training programs and educational initiatives have been implemented to improve clinicians' skills in inserting and managing intravenous access devices. This increased awareness and education have led to the wider use of intravenous access devices and their continued growth.Intravenous Access Devices Market was valued at US$ 52.8 Billion in 2024 and is projected to grow at a CAGR of 6.20% to reach US$ 96.6 Billion by 2034.

The report “Intravenous Access Devices Market, By Product Type (IV Catheters (Midline Peripheral Catheter, Central Catheters),  IV Infusion Pumps ( Parenteral Feeding Infusion Pumps, Intravenous Insulin Infusion Pumps, Intravenous Syringe Infusion Pumps, Intravenous Patient Controlled Analgesia Infusion Pumps), and IV Needles), By Catheters Type (Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Centrally Inserted Central Catheters, and Others), By End-user (Hospital & Clinics, Ambulatory Surgery Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends Analysis and Forecast till 2032 “

Key Highlights:

• In February 2022, B. Braun Medical Inc. announced the launch of the second of three courses that will provide training for pre-licensed students to include peripheral intravenous vascular access in accredited nursing, medical and allied health care educational programs. U.S. And the academic course is free for qualified universities and colleges internationally.
• In October 2022, Medtronic plc announced its intention to spin off the company's combined patient monitoring and respiratory interventions businesses, part of the company's medical surgical portfolio, a global leader in healthcare technology announced.
• In September 2016, Hospira, a Pfizer company and leading provider of infusion technology, announced the launch of the new LifeShield Supercath 5 safety I.V. Catheters in the United States. The new SuperCath 5 debuted at the Association for Vascular Annual Meeting in September in Orlando, Fla.

Analyst View:

Increasing healthcare spending and improving healthcare infrastructure in emerging markets present significant growth opportunities for the intravenous access devices market. Regulatory authorities are implementing stringent guidelines and standards to ensure the safety and efficacy of intravenous access devices. Compliance with these regulations is crucial for manufacturers to enter and expand in the market. The adherence to regulatory standards fosters innovation and quality improvement in intravenous access devices, supporting Intravenous Access Devices Market growth.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Intravenous Access Devices Market, By Product Type (IV Catheters (Midline Peripheral Catheter, Central Catheters),  IV Infusion Pumps ( Parenteral Feeding Infusion Pumps, Intravenous Insulin Infusion Pumps, Intravenous Syringe Infusion Pumps, Intravenous Patient Controlled Analgesia Infusion Pumps), and IV Needles), By Catheters Type (Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Centrally Inserted Central Catheters, and Others), By End-user (Hospital & Clinics, Ambulatory Surgery Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032”

Key Market Insights from the report:

Intravenous Access Devices Market was valued at US$ 52.8 Billion in 2024 and is projected to grow at a CAGR of 6.20% to reach US$ 96.6 Billion by 2034.. The Intravenous Access Devices Market is segmented based on Product Type, Catheters Type, End User, and Region.

• Based on Product Type, Intravenous Access Devices Market is segmented into IV Catheters (Midline Peripheral Catheter, Central Catheters),  IV Infusion Pumps ( Parenteral Feeding Infusion Pumps, Intravenous Insulin Infusion Pumps, Intravenous Syringe Infusion Pumps, Intravenous Patient Controlled Analgesia Infusion Pumps), and IV Needles.
• Based on Catheters Type, Intravenous Access Devices Market is segmented into Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Centrally Inserted Central Catheters, and Others.
• Based on End User, Intravenous Access Devices Market is segmented into Hospital & Clinics, Ambulatory Surgery Centers, and Others.
• By Region, the Intravenous Access Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Intravenous Access Devices Market:

The prominent players operating in the Intravenous Access Devices Market includes, Baxter International Becton, Dickinson and Company, Braun Melsungen AG, R. Bard, Inc., Covidien Plc, Fresenius Medical Care AG & Co., Hospira, Inc., Smith Medical, Teleflex, Inc., Galt Medical Corporation.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com